Literature DB >> 20966584

Cutaneous histoplasmosis in AIDS.

C Chande1, S Menon, A Gohil, S Lilani, J Bade, S Mohammad, A Joshi.   

Abstract

A patient with human immunodeficiency virus (HIV) infection presented with multiple cutaneous lesions on upper extremities, trunk, face and with ulcers involving oral mucosa. Histoplasma capsulatum was isolated in culture from scrapings from both cutaneous as well as oral mucosal lesions. The patient responded well initially to the treatment with Amphotericin B followed by itraconazole; however, lesions recurred after three months with the further deterioration of immune status of the patient indicated by decline in CD4 counts. The same treatment was restarted and the patient is still being followed-up.

Entities:  

Mesh:

Year:  2010        PMID: 20966584     DOI: 10.4103/0255-0857.71850

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  5 in total

1.  Oral histoplasmosis masquerading as oral cancer in HIV-infected patient: A case report.

Authors:  Shafiulla Mohammed; Mahua Sinha; Purushottam Chavan; Cs Premalata; Mr Shivaprakash; Arunaloke Chakrabarti; Rudrapatna S Jayshree
Journal:  Med Mycol Case Rep       Date:  2012-09-18

Review 2.  State of the art diagnostic of mold diseases: a practical guide for clinicians.

Authors:  F Beirão; R Araujo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-18       Impact factor: 3.267

3.  Cutaneous histoplasmosis in a HIV seronegative patient.

Authors:  Nandita Pal; Moumita Adhikary
Journal:  J Nat Sci Biol Med       Date:  2013-07

4.  Disseminated histoplasmosis: missed opportunistic infection in a HIV-infected patient.

Authors:  Anita Mehta; Shivang Desai; Nayan Desai; Anuradha Mookerjee
Journal:  BMJ Case Rep       Date:  2013-10-17

5.  Histoplasmosis presenting as isolated cervical lymphadenopathy: A rare presentation.

Authors:  Debi Prasad Mishra; Sindhu Ramamurthy; Samir Kumar Behera
Journal:  J Cytol       Date:  2015 Jul-Sep       Impact factor: 1.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.